Platform Study of Circulating Tumor DNA Directed Adjuvant Chemotherapy in Colon Cancer (KCSG CO22-12)

NCT05534087 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

236

Enrollment

OTHER

Sponsor class

Conditions

Colon Cancer

Interventions

DRUG: mFOLFIRINOX-FOLFIRI intensified chemotherapy
DRUG: FOLFOX or CAPOX adjuvant chemotherapy

Sponsor

Seoul National University Hospital